Over 150 senior IP and patent counsel joined the Munich event from companies including:AAKACP SecretariatAdidasAirbus DSAirbus GroupAllen & OveryAMGEN ResearchArnold RuessAudiB. Braun MelsungenBavarian NordicBioeqBMW GroupBrainlabBristowsCasalongaClariant ProdukteClifford ChanceContinental AutomotiveCrosslendDehnsDraexlmaierErich NetzschEricssonEuropean Patent InstituteEuropean Patent OfficeEZN Erfinderzentrum Norddeutschland Fraunhofer-Gesellschaft Freshfields Bruckhaus DeringerGE Wind EnergyGlobal Institute of Intellectual PropertyGowling WLGGrunenthalHelmholtzZentrum MunchenHitachiHogan LovellsHuawei TechnologiesInstitute of Intellectual PropertyITTJ. P. Peel & CoJohnson MattheyKather AugensteinKU Leuven Centre for IT & IP LawKUHNEN & WACKERLEONI Kabel HoldingLinde GroupLMU MunichMaiwald PatentanwaltsMarks & ClerkMax Planck Institute for Innovation and CompetitionMirkaMultiLingMundipharma InternationalMunich Intellectual Property Law CenterNEC EuropeNintendo of EuropeNokiaPotter ClarksonPowell GilbertSamsung Sandoz International SAPSiemensSiemens HealthcareTechnical University of MunichUK Intellectual Property OfficeUniversity of MacerataVDMAWeser & KollegenWIPO Arbitration and Mediation Centre Withers & Rogers`
Federal Circuit’s Brunetti ruling: barring immoral or scandalous marks is unconstitutional restriction of free spee… https://t.co/MivCKFINHg
Federal Circuit rules in Amgen v Sandoz on remand from SCOTUS https://t.co/uYIkfVhCHG https://t.co/2OZAscsz32
RT @mdloney: Canada moves closer to joining the Hague Agreement with the release of proposed new Industrial Design Regulations https://t.co…
End of Year 2017
Tribal sovereign immunity: Taking a wrecking ball to the IPR system
The lawyer behind Allergan’s controversial transfer of patents to a Native American tribe says others are “lining up to do deals”. But, Michael Loney asks, will the PTAB rule that sovereign immunity applies in these types of deals?
The material on this site is for financial institutions, professional investors
and their professional advisers. It is for information only. Please read our
Terms and Conditions
before using the site. All material subject to strictly enforced copyright laws.
© 2017 Euromoney Institutional Investor PLC. For help please
see our FAQ.
Switching to MIP International